5WHN
Crystal structure of the segment, NFGAFS, from the low complexity domain of TDP-43, residues 312-317
Summary for 5WHN
Entry DOI | 10.2210/pdb5whn/pdb |
Descriptor | Segment of TAR DNA-binding protein 43 (1 entity in total) |
Functional Keywords | amyloid, larks, tdp-43, protein fibril |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 641.67 |
Authors | Guenther, E.L.,Sawaya, M.R.,Eisenberg, D.S. (deposition date: 2017-07-17, release date: 2018-04-25, Last modification date: 2023-10-04) |
Primary citation | Guenther, E.L.,Cao, Q.,Trinh, H.,Lu, J.,Sawaya, M.R.,Cascio, D.,Boyer, D.R.,Rodriguez, J.A.,Hughes, M.P.,Eisenberg, D.S. Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregation. Nat. Struct. Mol. Biol., 25:463-471, 2018 Cited by PubMed Abstract: The normally soluble TAR DNA-binding protein 43 (TDP-43) is found aggregated both in reversible stress granules and in irreversible pathogenic amyloid. In TDP-43, the low-complexity domain (LCD) is believed to be involved in both types of aggregation. To uncover the structural origins of these two modes of β-sheet-rich aggregation, we have determined ten structures of segments of the LCD of human TDP-43. Six of these segments form steric zippers characteristic of the spines of pathogenic amyloid fibrils; four others form LARKS, the labile amyloid-like interactions characteristic of protein hydrogels and proteins found in membraneless organelles, including stress granules. Supporting a hypothetical pathway from reversible to irreversible amyloid aggregation, we found that familial ALS variants of TDP-43 convert LARKS to irreversible aggregates. Our structures suggest how TDP-43 adopts both reversible and irreversible β-sheet aggregates and the role of mutation in the possible transition of reversible to irreversible pathogenic aggregation. PubMed: 29786080DOI: 10.1038/s41594-018-0064-2 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.1 Å) |
Structure validation
Download full validation report